FDA Extends Comment Deadline on Proposed Animal Drug Reporting Scheme

The Food and Drug Administration (FDA) has extended the comment period
for an advanced notice of proposed rulemaking (ANPR) that announced
potential changes to regulations governing new antimicrobial animal drug
reporting. The ANPR proposed altering these regulations to incorporate the
requirements of section 105 of the Animal Drug User Fee Amendments of
2008 (ADUFA 105).

FDA has requested public comments “on how best to compile and present the
summary information as directed by ADUFA 105, and on alternative methods
available to the Agency for obtaining additional data and information about
the extent of antimicrobial drug use in food-producing animals.” FDA has
extended the comment period at the request of responders until November
26, 2012. See Federal Register, September 26, 2012.